Senior Health link

Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices – United States, 2025

January 12, 2026 3:00 am Published by Comments Off on Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices – United States, 2025
This report updates recommendations for the use meningococcal vaccine among people 10 years of age and older.

Learn More


Categorised in:

This post was written by senioradmin

Comments are closed here.

Chat Icon